Similar articles

• Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.

  Bangalore S, Kumar S, Lobach I, Messerli FH. Bangalore S, et al. Circulation. 2011 Jun 21;123(24):2799-810, 9 p following 810. doi: 10.1161/CIRCULATIONAHA.110.016337. Epub 2011 May 31. Circulation. 2011. PMID: 21632497
• Effect of short term intensive multitherapy on carotid intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus.

  Guo LX, Pan Q, Wang XX, Li H, Zhang LN, Chi JM, Wang Y. Guo LX, et al. Chin Med J (Engl). 2008 Apr 20;121(8):687-90. Chin Med J (Engl). 2008. PMID: 18701019 Clinical Trial.
• Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis.

  Zhang CY, Sun AJ, Zhang SN, Wu CN, Fu MQ, Xia G, Wang KQ, Zou YZ, Ge JB. Zhang CY, et al. Ann Med. 2010 May 6;42(4):305-15. doi: 10.3109/07853891003796752. Ann Med. 2010. PMID: 20429797
• Cardiovascular manifestations of insulin resistance.

  Chahwala V, Arora R. Chahwala V, et al. Am J Ther. 2009 Sep-Oct;16(5):e14-28. doi: 10.1097/MJT.0b013e3180a724b3. Am J Ther. 2009. PMID: 19114874 Review.
• Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.

  Tandon N, Ali MK, Narayan KM. Tandon N, et al. Am J Cardiovasc Drugs. 2012 Feb 1;12(1):7-22. doi: 10.2165/11594650-000000000-00000. Am J Cardiovasc Drugs. 2012. PMID: 22217193 Review.